| Literature DB >> 32153394 |
Decheng Bi1, Xiaofan Li1, Tong Li1, Xiuting Li2, Zhijian Lin3, Lijun Yao1, Hui Li1, Hong Xu1, Zhangli Hu1, Zhenqing Zhang4, Qiong Liu1, Xu Xu1.
Abstract
Seleno-polymannuronate (Se-PM) was prepared from alginate-derived polymannuronate (PM) through a sulfation followed by a selenylation replacement reaction. The organic selenium content of Se-PM was 437.25 μg/g and its average molecular weight was 2.36 kDa. The neuroprotection effect of Se-PM and corresponding molecular mechanisms were investigated. Our results showed that, comparing to both sulfated PM (S-PM) and PM, Se-PM remarkably inhibited the aggregation of Aβ1-42 oligomer in vitro and significantly reduced the APP and BACE1 protein expression in N2a-sw cells, highlighting the critical function of the selenium presented in Se-PM. Moreover, Se-PM decreased the expression of cytochrome c and the ratio of Bax to Bcl-2, and enhanced the mitochondrial membrane potential in N2a-sw cells. These results suggested that Se-PM treatment can markedly inhibit N2a-sw cell apoptosis and promote N2a-sw cell survival and that Se-PM might be a potential therapeutic agent for the prevention of neurodegeneration owing to its remarkable neuroprotection effect.Entities:
Keywords: N2a-sw cells; alginate; anti-apoptosis; neuroprotection; seleno-polymannuronate
Year: 2020 PMID: 32153394 PMCID: PMC7044149 DOI: 10.3389/fphar.2020.00021
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
Sulfur (S) content and DS of S-PM under four different experimental conditions.
| Sample | SO3-Py : PM (w/w) | Temperature (°C) | Time (h) | S (%) | DS |
|---|---|---|---|---|---|
| S-PM1 | 4:1 | 45 | 4 | 7.31 | 0.48 |
| S-PM2 | 4:1 | 60 | 4 | 8.41 | 0.58 |
| S-PM3 | 6:1 | 45 | 4 | 9.48 | 0.69 |
| S-PM4 | 6:1 | 60 | 4 | 11.86 | 0.97 |
Chemical characterization analysis of polysaccharide samples.
| Sample | MW (kDa) | DS | Se content (μg/g) |
|---|---|---|---|
| PM | 4.11 ± 0.27 | — | — |
| S-PM | 3.29 ± 0.06 | 0.97 | — |
| Se-PM | 2.37 ± 0.17 | 0.56 | 437.25 |
Figure 1FT-IR spectra of (A) PM, (B) S-PM, and (C) Se-PM.
Figure 2Effects of Se-PM on Aβ1–42 aggregation in vitro.
Figure 3Effects of polysaccharide samples on the APP and BACE1 expression levels in N2a-sw cells: (A) immunoblot, (B) statistical analysis. * p < 0.05, *** p < 0.001.
Figure 4Effects of Se-PM (0.5 mg/mL) on cell apoptosis in N2a-sw cells. (A, B) Immunofluorescence analysis of the mitochondrial membrane potential (A) and statistical analysis (B). (C, D) Immunofluorescence analysis of cytochrome c release (C) and statistical analysis (D). (E, F) Protein expression levels of Bax/Bcl-2, detected by Western blot analysis (E) and statistical analysis (F). Indicates significant differences between the N2a-sw cells and N2a cells, ##p < 0.01. *Indicates significant differences between the Se-PM-treated groups and control in N2a-sw cells, * p < 0.05. ** p < 0.01. Scale bar = 20 μm.